Rates of hypertension have been climbing in the U.S. in recent years, according to an analysis by Blue Cross Blue Shield, and they’re growing fastest among millennials and adults in their mid-thirties and forties.

Heart disease deaths are on the rise in the U.S., according to research published in the Journal of the American Medical Association Aug. 27—and they have been for almost a decade.

Oregon Health & Science University will resume its heart transplant services this month after nearly a year of inactivity, the university announced Aug. 26.

Early anticoagulation after bioprosthetic aortic valve replacement didn’t result in adverse clinical events or significantly affect aortic valve hemodynamics in a recent analysis of 4,832 heart patients, but it was linked to lower stroke rates in cases of SAVR.

Belgium-based Miracor Medical has secured FDA breakthrough device designation for its PiCSO Impulse System, an innovation designed to treat STEMI patients.

KentuckyOne Health is nixing its month-old plan to inactivate its heart transplant program at Jewish Hospital in Louisville, instead opting to work with the University of Louisville to keep the program alive.

Childhood cancer survivors are up to three times more likely than their cancer-free peers to develop various types of heart disease, according to an Aug. 26 study published in Circulation.

A multi-country study in Asia has revealed patients with both type 2 diabetes and heart failure face higher odds of structural CV abnormalities, a poorer quality of life and an increased risk of death.